Monrovia, Californina & Hangzhou, China – October 13, 2009 – Niusule Biotech Corp. (“Niusule” or the “Company”) (OTC BB: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company’s management team attended the ROTH China Conference, in Miami Beach, Florida from October 12-14, 2009.

In attendance at the ROTH China Conference was Niusule’s Chief Executive Officer, Amy Hu and Director, Jeff Tsang. The Company’s management team participated in one-on-one meetings with various potential investors, investment bankers, institutional shareholders, and analysts.

The ROTH China Conference featured presentations from a select group of US-listed Chinese companies that showcase areas with attractive growth potential. Over 60 companies presented at the conference, including US-listed Chinese companies and US-based companies with growth prospects in China. Most of the presenting companies are covered by ROTH's research team, which will be onsite for discussions with investors.

About Niusule Biotech Corp.

Niusule is engaged in the business of manufacturing, marketing and selling health food and related products. The Company manufactures mature health food products, including PlantFusion and Gummy Bears, in the United States and markets and distributes these products to Chinese consumers.  Niusule also maintains a strong focus on biotechnology R&D and is committed to becoming a leading player in China’s rapidly growing health food and bioengineering industry. The Company’s products are cultivated from natural plants and improved in flavors through R&D program with the Zhejiang University in China. Niusule’s products are manufactured in strict accordance with international standards. For more information, contact CCG Investor Relations directly or go to Niusule’s website at http://www.niusule.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions of the forward-looking statements contained herein to reflect future events or developments. You are urged to consider these factors care in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.